In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients.

OBJECTIVE Postmortem studies in schizophrenia reveal alterations in gene products that regulate the release and extracellular persistence of GABA. However, results of in vivo studies of schizophrenia measuring total tissue GABA with magnetic resonance spectroscopy (MRS) have been inconsistent. Neither the postmortem nor the MRS studies directly address the physiological properties of GABA neurotransmission. The present study addresses this question through an innovative positron emission tomography (PET) paradigm. METHOD The binding of [(11)C]flumazenil, a benzodiazepine-specific PET radiotracer, was measured before and after administration of tiagabine (0.2 mg/kg of body weight), a GABA membrane transporter (GAT1) blocker, in 17 off-medication patients with schizophrenia and 22 healthy comparison subjects. Increased extracellular GABA, through GAT1 blockade, enhances the affinity of GABAA receptors for benzodiazepine ligands, detected as an increase in [(11)C]flumazenil tissue distribution volume (VT). RESULTS [(11)C]Flumazenil VT was significantly increased across all cortical brain regions in the healthy comparison group but not in the schizophrenia group. This lack of effect was most prominent in the antipsychotic-naive schizophrenia group. In this subgroup, [(11)C]flumazenil ΔVT in the medial temporal lobe was correlated with positive symptoms, and baseline [(11)C]flumazenil VT in the medial temporal lobe was negatively correlated with visual learning. In the healthy comparison group but not the schizophrenia group, [(11)C]flumazenil ΔVT was positively associated with gamma-band oscillation power. CONCLUSIONS This study demonstrates, for the first time, an in vivo impairment in GABA transmission in schizophrenia, most prominent in antipsychotic-naive individuals. The impairment in GABA transmission appears to be linked to clinical symptoms, disturbances in cortical oscillations, and cognition.

[1]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[2]  Jong H. Yoon,et al.  GABA Concentration Is Reduced in Visual Cortex in Schizophrenia and Correlates with Orientation-Specific Surround Suppression , 2010, The Journal of Neuroscience.

[3]  Sarah H. Lisanby,et al.  Neuroimage: Clinical Gaba Level, Gamma Oscillation, and Working Memory Performance in Schizophrenia , 2022 .

[4]  R. Kerwin,et al.  Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. , 1997, The American journal of psychiatry.

[5]  K. Deisseroth,et al.  Parvalbumin neurons and gamma rhythms enhance cortical circuit performance , 2009, Nature.

[6]  Mark Slifstein,et al.  Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. , 2012, Archives of general psychiatry.

[7]  R. Coppola,et al.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.

[8]  Edith V. Sullivan,et al.  Cognitive and motor impairments are related to gray matter volume deficits in schizophrenia , 1996, Biological Psychiatry.

[9]  P. Jonas,et al.  Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks , 2007, Nature Reviews Neuroscience.

[10]  J. Tallman,et al.  GABAergic modulation of benzodiazepine binding site sensitivity , 1978, Nature.

[11]  David A. Lewis,et al.  Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia , 2012, Trends in Neurosciences.

[12]  F. Benes,et al.  Uncoupling of GABAA and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain , 1997, Brain Research.

[13]  J. Delforge,et al.  Parametric Images of Benzodiazepine Receptor Concentration Using a Partial-Saturation Injection , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  Yoshiyuki Asai,et al.  GABAA/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for α5 subunit , 2008, Schizophrenia Research.

[15]  Bard Ermentrout,et al.  When inhibition not excitation synchronizes neural firing , 1994, Journal of Computational Neuroscience.

[16]  A. Ducati,et al.  Neuronal and glial localization of GAT‐1, a high‐affinity γ‐aminobutyric acid plasma membrane transporter, in human cerebral cortex: With a note on its distribution in monkey cortex , 1998 .

[17]  J. Cohen,et al.  Functional hypofrontality and working memory dysfunction in schizophrenia. , 1998, The American journal of psychiatry.

[18]  W Singer,et al.  Visual feature integration and the temporal correlation hypothesis. , 1995, Annual review of neuroscience.

[19]  S. Rauch,et al.  Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance , 2000, Biological Psychiatry.

[20]  Z Rattner,et al.  Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]Flumazenil , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  R. Cho,et al.  Tiagabine Increases [11C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects , 2009, Neuropsychopharmacology.

[22]  Alexander Hammers,et al.  Acute increases in synaptic GABA detectable in the living human brain: A [11C]Ro15-4513 PET study , 2014, NeuroImage.

[23]  S. A. Wijtenburg,et al.  In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. , 2013, Schizophrenia bulletin.

[24]  J. Seibyl,et al.  SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  John Seibyl,et al.  No Evidence of Altered In Vivo Benzodiazepine Receptor Binding in Schizophrenia , 1999, Neuropsychopharmacology.

[26]  Kjell Någren,et al.  Measurement of GABAA receptor binding in vivo with [11C]Flumazenil: A test–retest study in healthy subjects , 2008, NeuroImage.

[27]  O. Bertrand,et al.  Oscillatory gamma activity in humans and its role in object representation , 1999, Trends in Cognitive Sciences.

[28]  C. Schroeder,et al.  Dysfunction of early-stage visual processing in schizophrenia. , 2001, The American journal of psychiatry.

[29]  J. Edgar,et al.  Gamma synchrony: Towards a translational biomarker for the treatment-resistant symptoms of schizophrenia , 2012, Neuropharmacology.

[30]  D E Kuhl,et al.  Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  D. Greenblatt,et al.  'GABA shift' in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA. , 1988, European journal of pharmacology.

[32]  Marc W Howard,et al.  Gamma oscillations correlate with working memory load in humans. , 2003, Cerebral cortex.

[33]  O. Bertrand,et al.  Sustained and transient oscillatory responses in the gamma and beta bands in a visual short-term memory task in humans , 1999, Visual Neuroscience.

[34]  Christoph Braun,et al.  Coherence of gamma-band EEG activity as a basis for associative learning , 1999, Nature.

[35]  A. Lajtha,et al.  Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses? , 1993, Neurochemical Research.

[36]  J. Krystal,et al.  [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia , 1999, Psychiatry Research: Neuroimaging.

[37]  Steven Warach,et al.  Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI , 1999, Biological Psychiatry.

[38]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.

[39]  Michael F. Green,et al.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. , 2008, The American journal of psychiatry.

[40]  F. Benes,et al.  Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects , 1996, Neuroscience.

[41]  T. Ohmori,et al.  GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study , 2010, Schizophrenia Research.

[42]  R. Yoshimura,et al.  Reduction of brain γ-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study , 2009, Schizophrenia Research.

[43]  Streichenwein Sm,et al.  Am J Psychiatry , 1996 .

[44]  Bita Moghaddam,et al.  From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment , 2012, Neuropsychopharmacology.

[45]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[46]  H. Mohler,et al.  Benzodiazepine receptor: demonstration in the central nervous system , 1977, Science.

[47]  C. Braestrup,et al.  High densities of benzodiazepine receptors in human cortical areas , 1977, Nature.

[48]  Dost Öngür,et al.  Elevated Gamma-Aminobutyric Acid Levels in Chronic Schizophrenia , 2010, Biological Psychiatry.

[49]  S. Kéri,et al.  Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: The potential impact of GABA concentration in the visual cortex , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[50]  D. Lewis,et al.  Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia , 2014, Current Opinion in Neurobiology.

[51]  M. Toru,et al.  Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics , 2005, European archives of psychiatry and neurological sciences.

[52]  N C Andreasen,et al.  Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. , 1992, Archives of general psychiatry.

[53]  Deborah A. Yurgelun-Todd,et al.  Functional magnetic resonance imaging in schizophrenia: cortical response to motor stimulation , 2004, Psychiatry Research: Neuroimaging.

[54]  D. Weinberger,et al.  Prefrontal function in schizophrenia: confounds and controversies. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[55]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[56]  W. Gordon Frankle,et al.  [11C]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels , 2012, PloS one.

[57]  H. Sauer,et al.  Benzodiazepine receptor distribution and diazepam binding in schizophrenia: an exploratory study , 1997, Psychiatry Research: Neuroimaging.

[58]  R. Narendran,et al.  Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. , 2005, Clinical therapeutics.

[59]  C. Carter,et al.  Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. , 2001, The American journal of psychiatry.

[60]  A. Deutch,et al.  The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. , 1994, Cerebral cortex.

[61]  B K Koe,et al.  [3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs. , 1987, European journal of pharmacology.

[62]  J. Krystal,et al.  Cortical γ-Aminobutyric Acid Levels Across the Menstrual Cycle in Healthy Women and Those With Premenstrual Dysphoric Disorder: A Proton Magnetic Resonance Spectroscopy Study , 2002 .

[63]  E. W. EMERY,et al.  Compartmental Analysis , 1970, Nature.

[64]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. , 1988, Archives of general psychiatry.